stockrowSTERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.
- Revenue
- +8.79%
- EPS
- +12.8%
- Free cash flow
- +43.6%
- Total debt
- −0.21%
Quarter to September 2026, against a year earlier
Follow STE
Alert me
STERIS plc (STE) EPS (diluted)
STERIS plc's EPS (diluted) for fiscal 2026 was $7.93, up 27.9% from $6.20 in fiscal 2025. Over the twelve months to 30 September 2026 it was $8.43. Over the past ten years it has ranged from $1.07 (fiscal 2023) to $7.93 (fiscal 2026) — the current reading is the highest in ten years. EPS (diluted) has risen for 3 consecutive fiscal years. STERIS plc ranks 5th of 147 Medical Devices companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2026 | $7.93 | 27.90% |
| FY2025 | $6.20 | 62.73% |
| FY2024 | $3.81 | 256.07% |
| FY2023 | $1.07 | (56.85%) |
| FY2022 | $2.48 | (46.44%) |
| FY2021 | $4.63 | (2.73%) |
| FY2020 | $4.76 | 33.71% |
| FY2019 | $3.56 | 5.01% |
| FY2018 | $3.39 | 164.84% |
| FY2017 | $1.28 | (17.95%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $2.19 | 7.35% |
| Jun 2026 | $2.04 | (8.93%) |
| Mar 2026 | $2.24 | 14.29% |
| Dec 2025 | $1.96 | 1.03% |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| STE STERIS plc | $8.43 |
| GEHC GE HealthCare Technologies Inc. compare | $4.76 |
| GMED Globus Medical, Inc. compare | $4.07 |
| PEN Penumbra, Inc. compare | $3.97 |
| ZBH Zimmer Biomet Holdings, Inc. compare | $3.96 |
| DXCM DexCom, Inc. compare | $2.55 |
| PHG Koninklijke Philips N.V. compare | $1.17 |
| SNN Smith & Nephew SNATS, Inc. compare | $1.13 |
| GKOS Glaukos Corporation compare | −$2.94 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on STE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement